Top

Journal of Medical Case Reports

Published in:

01-12-2020 | Photodynamic Therapy | Case report

Coupled blue and red light-emitting diodes therapy efficacy in patients with rosacea: two case reports

Authors: Elisabetta Sorbellini, Maria Pia De Padova, Fabio Rinaldi

Published in: Journal of Medical Case Reports | Issue 1/2020

Abstract

Background

Rosacea is a common inflammatory skin condition affecting approximately 5% of the world population. Therapeutic approaches to rosacea are focused on symptom suppression by means of anti-inflammatory agents. More recently, photodynamic therapy, especially light-emitting diodes, has been introduced as a valid alternative to conventional therapy.

Case presentation

In the present work, we reported the efficacy and safety of light-emitting diodes therapy combining blue (480 nm) and red (650 nm) light for the treatment of two patients with papulopustular rosacea: a 22-year-old Caucasian woman and a 68-year-old Caucasian man.

Conclusions

This kind of treatment could represent an effective, safer, and well-tolerated approach for the treatment of such conditions.

Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. J Am Acad Dermatol. 2015;72(5):749–58. quiz 759-60. PMID: 25890455PubMedCrossRef

Plewig G, Kligman AM. History of Acne and Rosacea. In: ACNE and ROSACEA. Berlin: Springer; 2000.CrossRef

Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013;69(6 Suppl 1):S15–26. Review. PMID: 24229632PubMedCrossRef

Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):S27–35. Review. PMID: 24229634PubMedCrossRef

Wilkin J, Dahl M, Detmar M, Drake L, Liang MH, Odom R, Powell F, National Rosacea Society Expert Committee. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907–12. PMID: 15153893PubMedCrossRef

Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powell F. Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol. 2002;46(4):584–7. PMID: 11907512PubMedCrossRef

Berg M, Lidén S. An epidemiological study of rosacea. Acta Derm Venereol. 1989;69(5):419–23. PMID: 2572109PubMed

Spoendlin J, Voegel JJ, Jick SS, Meier CR. A study on the epidemiology of rosacea in the U.K. Br J Dermatol. 2012;167(3):598–605. Epub 2012 Jul 23. PMID: 22564022PubMedCrossRef

Gether L, Overgaard LK, Egeberg A, Thyssen JP. Incidence and prevalence of rosacea: a systematic review and meta-analysis. Br J Dermatol. 2018;179(2):282–9. Epub 2018 May 31. Review. PMID: 29478264PubMed

10.

Rainer BM, Fischer AH, Luz Felipe da Silva D, Kang S, Chien AL. Rosacea is associated with chronic systemic diseases in a skin severity-dependent manner: results of a case-control study. J Am Acad Dermatol. 2015;73(4):604–8. Epub 2015 Aug 6. PMID: 26256428PubMedCrossRef

11.

Woo YR, Lim JH, Cho DH, Park HJ. Rosacea: Molecular Mechanisms and Management of a Chronic Cutaneous Inflammatory Condition. Int J Mol Sci. 2016;17(9) Review. PMID: 2764916

12.

Elewski BE, Draelos Z, Dréno B, Jansen T, Layton A, Picardo M. Rosacea - global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol. 2011;25(2):188–200. Epub 2010 Jun 25. PMID: 20586834PubMedCrossRef

13.

Steinhoff M, Buddenkotte J, Aubert J, Sulk M, Novak P, Schwab VD, Mess C, Cevikbas F, Rivier M, Carlavan I, Déret S, Rosignoli C, Metze D, Luger TA, Voegel JJ. Clinical, cellular, and molecular aspects in the pathophysiology of rosacea. J Investig Dermatol Symp Proc. 2011;15(1):2–11. Review. PMID: 22076321PubMedPubMedCentralCrossRef

14.

Del Rosso JQ, Gallo RL, Tanghetti E, Webster G, Thiboutot D. An evaluation of potential correlations between pathophysiologic mechanisms, clinical manifestations, and management of rosacea. Cutis. 2013;91(3 Suppl):1–8. Review. PMID: 23833998PubMed

15.

Cribier B. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Ann Dermatol Venereol. 2011;138 Suppl 3:S184–91. PMID: 22183097PubMedCrossRef

16.

Yamasaki K, Gallo RL. Rosacea as a disease of cathelicidins and skin innate immunity. J Investig Dermatol Symp Proc. 2011;15(1):12–5. PMID: 22076322PubMedCrossRef

17.

Schauber J, Gallo RL. Antimicrobial peptides and the skin immune defense system. J Allergy Clin Immunol. 2008;122(2):261–6. Epub 2008 Apr 25. Review. PMID: 18439663PubMedPubMedCentralCrossRef

18.

Vaughn AR, Notay M, Clark AK, Sivamani RK. Skin-gut axis: The relationship between intestinal bacteria and skin health. World J Dermatol. 2017;6(4):52–8.CrossRef

19.

Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol. 2011;131(10):1974–80. Epub 2011 Jun 23. Review. PMID: 21697881PubMedPubMedCentralCrossRef

20.

Ng QX, Soh AYS, Loke W, Lim DY, Yeo WS. The role of inflammation in irritable bowel syndrome (IBS). J Inflamm Res. 2018;11:345–9. PMID: 30288077PubMedPubMedCentralCrossRef

21.

Holmes AD. Potential role of microorganisms in the pathogenesis of rosacea. J Am Acad Dermatol. 2013;69(6):1025–32. Epub 2013 Sep 5. PMID: 24011460PubMedCrossRef

22.

Parodi A, Paolino S, Greco A, Drago F, Mansi C, Rebora A, Parodi A, Savarino V. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clin Gastroenterol Hepatol. 2008;6(7):759–64. Epub 2008 May 5. PMID: 18456568PubMedCrossRef

23.

Picardo M, Ottaviani M. Skin microbiome and skin disease: the example of rosacea. J Clin Gastroenterol. 2014;48(Suppl 1):S85–6. Review. PMID: 25291137PubMedCrossRef

24.

Zaidi AK, Spaunhurst K, Sprockett D, Thomason Y, Mann MW, Fu P, Ammons C, Gerstenblith M, Tuttle MS, Popkin DL. Characterization of the facial microbiome in twins discordant for rosacea. Exp Dermatol. 2018;27(3):295–8. PMID: 29283459PubMedPubMedCentralCrossRef

25.

Di Nardo A, Holmes AD, Muto Y, Huang EY, Preston N, Winkelman WJ, Gallo RL. Improved clinical outcome and biomarkers in adults with papulopustular rosacea treated with doxycycline modified-release capsules in a randomized trial. J Am Acad Dermatol. 2016;74(6):1086–92. Epub 2016 Mar 5. PMID: 26951940PubMedCrossRef

26.

Del Rosso JQ, Webster GF, Jackson M, Rendon M, Rich P, Torok H, Bradshaw M. Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea. J Am Acad Dermatol. 2007;56(5):791–802. Epub 2007 Mar 23 PMID: 17367893PubMedCrossRef

27.

Wise RD. Submicrobial doxycycline and rosacea. Compr Ther. 2007;33(2):78–81. PubMed PMID: 18004018PubMedCrossRef

28.

Cardwell LA, Alinia H, Moradi Tuchayi S, Feldman SR. New developments in the treatment of rosacea - role of once-daily ivermectin cream. Clin Cosmet Investig Dermatol. 2016;9:71–7. eCollection 2016. Review. PMID: 27051311PubMedPubMedCentralCrossRef

29.

Coda AB, Hata T, Miller J, Audish D, Kotol P, Two A, Shafiq F, Yamasaki K, Harper JC, Del Rosso JQ, Gallo RL. Cathelicidin, kallikrein 5, and serine protease activity is inhibited during treatment of rosacea with azelaic acid 15% gel. J Am Acad Dermatol. 2013;69(4):570–7. Epub 2013 Jul 18. PMID: 23871720PubMedPubMedCentralCrossRef

30.

Del Rosso JQ. Evaluating the role of topical therapies in the management of rosacea: focus on combination sodium sulfacetamide and sulfur formulations. Cutis. 2004;73(1 Suppl):29–33. Review. PMID: 14959943PubMed

31.

Two AM, Wu W, Gallo RL, Hata TR. Rosacea: part II. Topical and systemic therapies in the treatment of rosacea. J Am Acad Dermatol. 2015;72(5):761–70. quiz 771-2. Review. PMID: 25890456PubMedCrossRef

32.

van Zuuren EJ, Fedorowicz Z. Low-Dose Isotretinoin: An Option for Difficult-to-Treat Papulopustular Rosacea. J Invest Dermatol. 2016;136(6):1081–3. Review PMID: 27212646PubMedCrossRef

33.

Mehrotra AN, Thomas Z, Goyal VP. Gastrointestinal side effects of tetracycline and its possible prevention by antifungal compounds. J Assoc Physicians India. 1970;18(7):627–9. PubMed PMID: 5473878PubMed

34.

Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232–60. second page, table of contents. PubMed PMID: 11381101PubMedPubMedCentralCrossRef

35.

Two AM, Hata TR, Nakatsuji T, Coda AB, Kotol PF, Wu W, Shafiq F, Huang EY, Gallo RL. Reduction in serine protease activity correlates with improved rosacea severity in a small, randomized pilot study of a topical serine protease inhibitor. J Invest Dermatol. 2014;134(4):1143–5. Epub 2013 Nov 8. PMID: 24213369PubMedCrossRef

36.

Triesscheijn M, Baas P, Schellens JH, Stewart FA. Photodynamic therapy in oncology. Oncologist. 2006;11(9):1034–44. Review. PMID: 17030646PubMedCrossRef

37.

Li X, Guo H, Tian Q, Zheng G, Hu Y, Fu Y, Tan H. Effects of 5-aminolevulinic acid-mediated photodynamic therapy on antibiotic-resistant staphylococcal biofilm: an in vitro study. J Surg Res. 2013;184(2):1013–21. Epub 2013 Apr 18 PMID: 23622723PubMedCrossRef

38.

Bryld LE, Jemec GB. Photodynamic therapy in a series of rosacea patients. J Eur Acad Dermatol Venereol. 2007;21(9):1199–202. PMID: 17894705PubMed

39.

Lee JB, Bae SH, Moon KR, Na EY, Yun SJ, Lee SC. Light-emitting diodes downregulate cathelicidin, kallikrein and toll-like receptor 2 expressions in keratinocytes and rosacea-like mouse skin. Exp Dermatol. 2016;25(12):956–61. Epub 2016 Oct 3. PMID: 27315464PubMedCrossRef

40.

Feldman SR, Huang WW, Huynh TT. Current drug therapies for rosacea: a chronic vascular and inflammatory skin disease. J Manag Care Spec Pharm. 2014;20(6):623–9. Review. PMID: 24856600PubMed

41.

Asai Y, Tan J, Baibergenova A, Barankin B, Cochrane CL, Humphrey S, Lynde CW, Marcoux D, Poulin Y, Rivers JK, Sapijaszko M, Sibbald RG, Toole J, Ulmer M, Zip C. Canadian Clinical Practice Guidelines for Rosacea. J Cutan Med Surg. 2016;20(5):432–45. Epub 2016 May 17. Review. PMID: 27207355PubMedCrossRef

42.

Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007;39(2):180–8. PMID: 17111415PubMedCrossRef

43.

Kwon HH, Lee JB, Yoon JY, Park SY, Ryu HH, Park BM, Kim YJ, Suh DH. The clinical and histological effect of home-use, combination blue-red LED phototherapy for mild-to-moderate acne vulgaris in Korean patients: a double-blind, randomized controlled trial. Br J Dermatol. 2013;168(5):1088–94. PMID: 23278295PubMedCrossRef

44.

Friedmann DP, Goldman MP, Fabi SG, Guiha I. The effect of multiple sequential light sources to activate aminolevulinic Acid in the treatment of actinic keratoses: a retrospective study. J Clin Aesthet Dermatol. 2014;7(9):20–5. PMID: 25276272PubMedPubMedCentral

45.

Smith KR, Thiboutot DM. Thematic review series: skin lipids. Sebaceous gland lipids: friend or foe? J Lipid Res. 2008;49(2):271–81. Epub 2007 Nov 1. Review. PMID: 17975220PubMedCrossRef

46.

Charakida A, Seaton ED, Charakida M, Mouser P, Avgerinos A, Chu AC. Phototherapy in the treatment of acne vulgaris: what is its role? Am J Clin Dermatol. 2004;5(4):211–6. Review. PubMed PMID: 15301568PubMedCrossRef

47.

Ablon G. Phototherapy with Light Emitting Diodes: Treating a Broad Range of Medical and Aesthetic Conditions in Dermatology. J Clin Aesthet Dermatol. 2018;11(2):21–7. Epub 2018 Feb 1. Review. PMID: 29552272PubMedPubMedCentral

48.

Sorbellini E, Rucco M, Rinaldi F. Photodynamic and photobiological effects of light-emitting diode (LED) therapy in dermatological disease: an update. Lasers Med Sci. 2018;33(7):1431–9. Epub 2018 Jul 14. Review. PMID: 30006754PubMedPubMedCentralCrossRef

49.

Pei S, Inamadar AC, Adya KA, Tsoukas MM. Light-based therapies in acne treatment. Indian Dermatol Online J. 2015;6(3):145–57. Review. PMID: 26009707PubMedPubMedCentralCrossRef

50.

Dong Y, Zhou G, Chen J, Shen L, Jianxin Z, Xu Q, Zhu Y. A new LED device used for photodynamic therapy in treatment of moderate to severe acne vulgaris. Photodiagn Photodyn Ther. 2016;13:188–95. Epub 2015 Jun 23. PMID: 26116283CrossRef

51.

Schreiber S. A Novel Regimen for Perioral Dermatitis by Photodynamic Therapy. J Pharm Pharmacol. 2016;4:559–63.

52.

Nybaek H, Jemec GB. Photodynamic therapy in the treatment of rosacea. Dermatology. 2005;211(2):135–8. PMID: 16088160PubMedCrossRef

53.

Katz B, Patel V. Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea. J Drugs Dermatol. 2006;5(2 Suppl):6–8. PMID: 16485874PubMed

54.

Cecic I, Sun J, Korbelik M. Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells. Photochem Photobiol. 2006;82(2):558–62. PMID: 16613513PubMedCrossRef

55.

Noborio R, Nishida E, Kurokawa M, Morita A. A new targeted blue light phototherapy for the treatment of acne. Photodermatol Photoimmunol Photomed. 2007;23(1):32–4. PMID: 17254034PubMedCrossRef

56.

Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, Shalita AR, Lozada VT, Berson D, Finlay A, Goh CL, Herane MI, Kaminsky A, Kubba R, Layton A, Miyachi Y, Perez M, Martin JP, Ramos-E-Silva M, See JA, Shear N, Wolf J Jr, Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol. 2009;60(5 Suppl):S1–50. Review. PMID: 19376456PubMedCrossRef

57.

Kumar A, Ghate V, Kim MJ, Zhou W, Khoo GH, Yuk HG. Antibacterial efficacy of 405, 460 and 520 nm light emitting diodes on Lactobacillus plantarum, Staphylococcus aureus and Vibrio parahaemolyticus. J Appl Microbiol. 2016;120(1):49–56. PMID: 26481103PubMedCrossRef

58.

Cicarma E, Mørk C, Porojnicu AC, Juzeniene A, Tam TT, Dahlback A, Moan J. Influence of narrowband UVB phototherapy on vitamin D and folate status. Exp Dermatol. 2010;19(8):e67–72. PMID: 19849714PubMedCrossRef

Title: Coupled blue and red light-emitting diodes therapy efficacy in patients with rosacea: two case reports
Authors: Elisabetta Sorbellini
Maria Pia De Padova
Fabio Rinaldi
Publication date: 01-12-2020
Publisher: BioMed Central
Keywords: Photodynamic Therapy
Acne
Rosacea
Published in: Journal of Medical Case Reports / Issue 1/2020
Electronic ISSN: 1752-1947
DOI: https://doi.org/10.1186/s13256-019-2339-6

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Coupled blue and red light-emitting diodes therapy efficacy in patients with rosacea: two case reports

Abstract

Background

Case presentation

Conclusions

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Case presentation

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

Late-onset ovarian hyperstimulation syndrome developing during ovarian stimulation in an ectopic pregnancy: a case report

Venous thromboembolism and COVID-19: a case report and review of the literature

Miller Fisher syndrome with bilateral vocal cord paralysis: a case report

Pericardial effusion and cardiac tamponade requiring pericardial window in an otherwise healthy 30-year-old patient with COVID-19: a case report

Adult Langerhans cell histiocytosis presenting with multisystem involvement and sarcomatoid features: a case report

Hydralazine-induced antineutrophil cytoplasmic antibody-associated vasculitis with pulmonary–renal syndrome: a case report